Pills

GoodRx, the Expedia of prescription drugs, surges 40% after going public

Snacks / Wednesday, September 23, 2020

Not to be confused with RXBAR... This one won't get stuck in your teeth. GoodRx is a price comparison app for prescription drugs at local pharmacies. It offers free lists of discounts/coupons to cut prescription med costs. Like the Expedia of pills, GoodRx uses 150B pricing data points to show you the best deals for that blood pressure issue.

  • GoodRx raised over $1B in its IPO on Tuesday night from "VIP" institutional investors (they get 1st dibs) who bought it at $33/share.
  • The stock soared 53% Wednesday after GoodRx went public on the Nasdaq (for the rest of us), ending the day at $49/share.

This IPO jump actually makes sense... Nikola's stock doubled after its IPO and it hit a $19B market value without ever having sold a product. GoodRx is also now worth $19B — but it's the rare tech IPO whose business is actually profitable.

  • It makes $$$ by collecting fees from the pharmacy benefits managers it works with (essentially, referral fees) — it has been profitable since 2016.
  • It's growing fast. In just the 1st half of 2020, GoodRx made almost as much profit as it did in all of 2019 — $55M vs. $66M for all of 2019.

Healthcare is the last frontier of consumer tech disruption... GoodRX is the #1 most downloaded medical app with ~5M users because it fills two major gaps in healthcare: lack of affordability and lack of simplicity. Pharmaceuticals in America are so overpriced that there's plenty of room to undercut prices and still profit. GoodRx makes meds accessible with its app and presents us with actual options so we can comparison shop.

Get Your News

Subscribe and thrive

Snacks provides fresh takes on the financial news you need to start your day. Chartr provides data visualizations on business, entertainment, and society. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.